Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baxter InternationalBAX +0.57%70 3-Year Book Growth Rate is 1.00% as of Jun. 2026, which is 17% below its 10-year median of 1.20. GuruFocus rates BAX with a GF Score™ of 70/100 and a GF Value™ of $31.68 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 757 Medical Devices & Instruments companies, Baxter International ranks worse than 53.63% on this metric.
During the past 12 months, Baxter International's average Book Value per Share Growth Rate was -15.80% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 1.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -6.40% per year.
During the past 10 years, the average Book Value per Share Growth Rate was -2.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Baxter International was 22.00% per year. The lowest was -10.80% per year. And the median was 1.20% per year.
Baxter International (NYSE:BAX) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Baxter International 3-Year Book Growth Rate Related Terms
BAX vs COO, SOLV, ALGN: 3-Year Book Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Baxter International's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Baxter International's 3-Year Book Growth Rate falls into.
Baxter International 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 1.00% mean?
Baxter International (BAX) has a 3-Year Book Growth Rate of 1.00% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Baxter International and its competitors. This is 17% below median its historical median of 1.20. According to the industry distribution chart, Baxter International ranks #406 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 53.6%.
Is Baxter International's 3-Year Book Growth Rate too high?
Baxter International's current 3-Year Book Growth Rate of 1.00% is 17% below median its 10-year median of 1.20. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.30. Baxter International's value of 1.00% is 56.5% below this industry median. Based on the distribution chart, Baxter International ranks #406 out of 757 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Baxter International has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Baxter International's 3-Year Book Growth Rate compare to COO and SOLV?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #406 out of 757 companies for 3-Year Book Growth Rate. This places Baxter International in the lower half of its industry. The industry median 3-Year Book Growth Rate is 2.30. Baxter International's value of 1.00% is 56.5% below this benchmark. While the company's 10-year median is 1.20 vs. the industry median of 2.30, Baxter International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baxter International's current 3-Year Book Growth Rate of 1.00% is 56.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Baxter International and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baxter International's current 3-Year Book Growth Rate is 1.00%, which is 17% below median its own 10-year median of 1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (BAX) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.68, compared to a current price of $22.93 — trading 27.6% below its estimated fair value. The current 3-Year Book Growth Rate is 1.00%, which is 17% below median its 10-year median of 1.20 and 56.5% below the Medical Devices & Instruments industry median of 2.30. Baxter International's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Baxter International (BAX), the current 3-Year Book Growth Rate is 1.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (BAX) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of $22.93 is trading 27.6% below its estimated GF Value™ of $31.68.
GuruFocus considers Baxter International to be Modestly Undervalued.
Key valuation signals for BAX:
3-Year Book Growth Rate: 1.00% (17% below median its 10-year median of 1.20)
GF Value™: $31.68 vs. price of $22.93 (27.6% below fair value)
Industry Position: 56.5% below the Medical Devices & Instruments median (#406 of 757)
No single metric tells the full story. See the BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
70GF Score
Get the complete analysis for BAX
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BAX has been successfully added to your 
